I also note that, although the historic studies on this treatment do not stack up scientifically or to a satisfactory level to appease European regulatory bodies, the company continues to quote the (worthless) studies in all major presentations. They are completely irrelevant to the progression of this technology and the company has morphed its message into trials that will definitely show advantage and guarantee teh CE mark and FDA approval. VERY expensive trials with NO guarantee of outcome taking many months and probably years. The message all along from this company borders on fraudulent and definitely has omitted key information at numerous levels.
I watch this company as I have an interest in Biomedical stocks. I sold a while ago but always considered a re-entry. But it is just way too far off with a management team who are proving to be great at spruiking but poor at delivery.
Tyremen
OSL Price at posting:
11.0¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)